Secondary endpoints were changes from baseline in mean 24 h ABPM [ diastolic blood pressure ( DBP ) ] after the first day of therapy with OM/AM/HCTZ 40/10/25 mg ; mean changes from baseline in trough seated SBP ( SeSBP ) at day 1 and SeSBP at weeks 1 , 2 , 3 and 4 ; mean changes from baseline in trough seated DBP ( SeDBP ) at day 1 and SeDBP at weeks 1 , 2 , 3 and 4 ; and the percentage of subjects achieving mean 24 h , daytime and night-time ABPM BP goals .